Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 May;408(6):628-33.
doi: 10.1007/BF00581166.

A study of the post-tetanic twitch depression at the prostatic end of the rat vas deferens

A study of the post-tetanic twitch depression at the prostatic end of the rat vas deferens

N I Amobi et al. Pflugers Arch. 1987 May.

Abstract

The effects of different drugs on the post-tetanic twitch responses of the prostatic end of the isolation rat vas deferens were examined. Following repetitive field stimulation (4-5 Hz for 40-60 s), the post-tetanic twitches (0.2-0.5 Hz) were depressed relative to the steady-state pretetanic twitches. Maximum post-tetanic twitch depression (PTD) occurred 15-30 s after the tetanic stimulation. The PTD was not reversed but deepened and prolonged by the presynaptic alpha 2-adrenoceptor antagonists idazoxan (RX781094) or yohimbine (10(-7) M) alone or combined with the neuronal uptake blocker, desipramine (10(-6) M). The PTD was insensitive to the beta-adrenoceptor blocker, propranolol (10(-6) M), the P1-purinoceptor antagonist, 8-phenyltheophylline (10(-5) M) or the prostaglandin E synthesis inhibitor, indomethacin (10(-6) M). Pre- and post-tetanic contractions to superfused noradrenaline (NA), adenosine 5'-triphosphate (ATP), or beta, gamma-methylene ATP (beta, gamma-mATP) (bolus injections into superfusate, 1-8 X 10(-5) M) were not significantly (p less than 0.01) different. The PTD was absent in high magnesium (6.2-11.2 mM) solutions. These results are consistent with the PTD having an intrinsic presynaptic origin. They are discussed in relation to stimulation-induced modulation of transmitter release.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Arch Int Pharmacodyn Ther. 1970 Jun;185(2):406-12 - PubMed
    1. J Physiol. 1970 May;208(1):30P-32P - PubMed
    1. Br J Pharmacol. 1983 Jan;78(1):221-31 - PubMed
    1. Eur J Pharmacol. 1976 Nov;40(1):153-62 - PubMed
    1. Neuroscience. 1982;7(11):2565-76 - PubMed